As the number of children infected with the human immunodeficiency virus (HIV) continues to grow, it is important for early childhood practitioners to understand the potential effects of this disease on infants' and children's functioning. Infants and children with symptomatic HIV disease may exhibit a wide range of neurocognitive, social-emotional, and behavioral difficulties. Therefore, assessment professionals must be prepared to build a profile of the child's functioning that reflects current strengths and weaknesses and provides a baseline for comparison in future evaluations. Because the effects of this disease are direct (e.g., neurological impairment) as well as indirect (e.g., personal or parental anxiety from living with the disease), professionals may need a wide range of assessment tools to perform valid evaluations. This article provides a guide to help early interventionists to understand the basic pathology of this disease, to recognize the direct and indirect manifestations of the disease, and to choose assessment protocols appropriate for this population.
Get full access to this article
View all access options for this article.
References
1.
Aylward, E. H., Butz, A. M., Hutton, N., Joyner, M. L., & Vogelhut, J. W. (1992). Cognitive and motor development of infants at risk for human immunodeficiency virus. American Journal of Diseases of Children, 146, 218–222.
2.
Bagnato, S. J., & Neisworth, J. T. (1991). Assessment for early intervention: Best practices for professionals. New York: Guilford Press.
3.
Bailey, D. B. (1991). Issues and perspectives on family assessment. Infants and Young Children, 4, 26–34.
4.
Bailey, D. B., & Simeonsson R.J. (1988). Family assessment in early intervention.Columbus, OH: Merrill.
5.
Bayer, R. (1994). Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV. The New England Journal of Medicine, 331, 1223–1225.
6.
Belman, A. L. (1990). AIDS and pediatric neurology. Neurology Clinics, 8, 571–603.
7.
Belman, A. L., Diamond, G., Dickson, D., Horoupian, D., Liena, J., Lantos, G., & Rubenstein, A. (1988). Pediatric acquired immunodeficiency syndrome: Neurologic syndromes. American Journal of Diseases of Children, 142, 29–35.
8.
Brouwers, P., Belman, A., & Epstein, L. (1994). Organ-specific complications: Central nervous system involvement: Manifestations, evaluation, and pathogenesis. In P. A. Pizzo & C. M. Wilfert (Eds.), Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents (pp. 433–455). Baltimore: Williams & Wilkins.
9.
Brouwers, P., Moss, H., Wolters, P., Eddy, J., Ballis, F., Poplack, D. G., & Pizzo, P. A. (1990). Effect of continuous infusion zidovudine therapy on neuropsychological functioning in children with symptomatic human immunodeficiency virus infection. Journal of Pediatrics, 117, 980–985.
10.
Butler, K. M., Husson, R. N., Balis, F. M., Brouwers, P., Eddy, J., El-Amin, D., Gress, J., Hawkins, M., Jarosinski, P., Moss, H., Poplack, D., Santacroce, S., Venzon, D., Wiener, L., Wolters, P., & Pizzo, P. A. (1991). Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. New England Journal of Medicine, 324, 137–144.
11.
Cao, Y., Krogstad, P., Korber, B. T., Koup, R. A., Muldoon, M., Macken, C., Song, J. L., Jin, Z., Zhao, J. Q., Clapp, S., Chen, I. S., Ho, D. D., & Ammann, A. J. (1997). Maternal HIV-1 viral load and vertical transmission of infection: The Ariel project for the prevention of HIV transmission from mother to infant. National Medicine, 3, 549–552.
12.
Centers for Disease Control and Prevention. (1996). The Florida AIDS, STD, and TB Monthly Surveillance Report, 139.Atlanta: U.S. Department of Health and Human Services.
13.
Clarick, R. H., Hanecom, W. A., Yogev, R., & Chadwick, E. G. (1997). Megestrol acetate treatment of growth failure in children infected with the human immunodeficiency virus. Pediatrics, 99, 354–357.
14.
Cohen, H. J., Papola, P., & Alvarez, M. (1994). Neurodevelopmental abnormalities in school-age children with HIV infection. Journal of School Health, 64, 11–13.
15.
Connor, E. M., Sperling, R. S., Gelber, R., Kiselev, P., Scott, G., O'Sullivan, M. J., Van Dyke, R., Bey, M., Shearer, W., Jacobson, R. L., Jimenez, E., O'Neill, E., Bazin, B., Delfraissy, J. F., Culnane, M., Coombs, R., Elkins, M., Moye, J., Stratton, P., & Balsley, J. (1994). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. The New England Journal of Medicine, 331, 1173–1180.
16.
Coulter, D. L., & Chase, C. (1990). Neurological assessment of infants and young children with HIV infection. In P. B. Kozlowski, D. A. Snider, P. M. Vietze, & H. M. Wisniewski (Eds.), Brain and pediatric AIDS (pp. 80–90). New York: Karger.
17.
Diamond, G. W., & Cohen, H. J. (1992). Developmental disabilities in children with HIV infection. In A. C. Crocker, H. J. Cohen, & T. A. Kastner (Eds.), HIV infection and developmental disabilities: A resource for service providers (pp. 33–42). Baltimore: Brookes.
18.
Dunst, C. J., Trivette, C., & Deal, A. (1988). Enabling and empowering families: Principles and guidelines for practice.Cambridge, MA: Brookline.
19.
Dwyer, D. E., & Kesson, A. M. (1997). Advances in antiviral therapy. Current Opinion in Pediatrics, 9, 24–30.
20.
Epstein, L. G., Sharer, L. R., Oleske, J. M., Connor, E. M., Goudsmit, J., Bagdon, L., Robert-Guroff, M., & Koenigsberger, M. R. (1986). Neurologic manifestations of human immunodeficiency virus in children. Pediatrics, 78, 678–687.
21.
Ferguson, D. M., Horwood, L. J., & Lawton J.M. (1990). Vulnerability to childhood problems and family social background. Journal of Child Psychology and Psychiatry, 31, 1145–1160.
22.
Frank, E. G., Foley, G. M., & Kuchuk, A. (1997). Cognitive functioning in school-age children with human immunodeficiency virus. Perceptual and Motor Skills, 85, 267–272.
23.
Friedland, G., & Klein, R. (1987). Transmission of the human immunodeficiency virus. The New England Journal of Medicine, 317, 1125–1135.
24.
Gendelman, H. E., Genis, P., Jett, M., Zhai, Q. H., & Nottet, H. S. (1994). An experimental model system for HIV-1 induced brain injury. Advances in Neuroimmunology, 4, 189–193.
25.
Havens, P. L., Cuene, B. E., Waters, D., Hand, J., & Chusid, M. J. (1997). Structure of a primary care support system to coordinate comprehensive care for children and families infected/affected by human immunodeficiency virus in a managed care environment. Pediatric Infectious Disease Journal, 16, 211–216.
26.
Henggeler, S. W., Melton, G. B., Rodriguez, J. R. (1992). Pediatric and adolescent AIDS: Research findings from the social sciences.Newbury Park, CA: Sage.
27.
Individuals with Disabilities Education Act of 1990, 20 U.S.C. $$1400 et seq.
28.
Jay, C., & Dalakas, C. (1994). Myopathies and neuropathies in HIV-infected adults and children. In P. A. Pizzo & C. M. Wilfert (Eds.), Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents (pp. 433–455). Baltimore: Williams & Wilkins.
29.
Karlsson, K., Massawe, A., Urassa, E., Kawo, G., Msemo, G., Kazimoto, T., Lyamuya, E., Mbena, E., Urassa, W., Bredberg-Raden, U., Mhalu, F., & Biberfeld, G. (1997). Late postnatal transmission of human immunodeficiency virus type 1 infection from mothers to infants in Dar es Salaam, Tanzania. Pediatric Infectious Disease Journal, 16, 963–967.
30.
Katz, D. A. (1997). The profile of HIV infection in women: A challenge to the profession. Social Work Health Care, 24, 127–134.
31.
Kellerman, J., Zeltzer, L., & Ellenberg, L. (1980). Psychological effects of illness in adolescents: Anxiety, self-esteem, and perceptions of control. Journal of Pediatrics, 97, 126–131.
32.
Luzuriaga, K., Bryson, Y., Krogstad, P., Robinson, J., Stechenberg, B., Lamson, M., Cort., S., & Sullivan, J. L. (1997). Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. The New England Journal of Medicine, 336, 1343–1349.
33.
MacDonald, M. (1992). Vertical transmission of HIV: Management of the pregnant mother and her infant. In M. L. Stuber (Ed.), Children and AIDS. Washington, DC: American Psychiatric Press.
34.
Massachusetts Medical Society. (1996, November). Morbidity and Mortality Weekly Report, 45, 1005–1010.
35.
Meyers, A. (1994). Natural history of congenital HIV infection. Journal of School Health, 64, 9–10.
36.
Mintz, M., Rapaport, R., Oleske, J. M., Connor, E. M., Koenigsberger, M. R., Denny, T., & Epstein, L. G. (1989). Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. American Journal of Diseases in Childhood, 143, 771–774.
37.
Mofenson, L. M. (1997). Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions. Acta Paediatrica Supplement, 421, 1–9.
38.
Moss, H. A., Brouwers, P., Wolters, P. L., Weiner, L., Hersh, S., & Pizzo, P. A. (1994). The development of a Q-sort behavioral rating procedure for pediatric HIV patients. Journal of Pediatric Psychology, 19, 27–46.
39.
Neuchterlein, K. H., Parasuraman, R., & Jiang, Q. (1983). Visual sustained attention: Image degradation produces rapid sensitivity decrement over time. Science, 200, 327–329.
40.
Odom, S., & McLean, M. (Eds.) (1990). DEC recommended practices: indicators of quality in programs for infants and young children with special needs and their families.Reston, VA: Council for Exceptional Children.
41.
Oleske, J. M. (1990). AIDS in our children—Who cares for them? Issues of Law and Medicine, 5, 437–450.
42.
Oleske, J., Minnefor, A., Cooper, R., Thomas, K., dela Cruz, A., Guerrero, I., Joshi, V. V., & Desposito, F. (1983). Immune deficiency syndrome in children. Journal of the American Medical Association, 249, 2345–2349.
43.
Pizzo, P., Eddy, J., Falloon, J., Balis, F., Murphy, R., Moss, H., Wolters, P., Brouwers, P., Jarosinski, P., Rubin, M., Broder, S., Yarchoan, R., Brunetti, A., Maha, M., Nusinoff-Lehrman, S., & Poplack, D. (1988). Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. The New England Journal of Medicine, 319, 889–896.
44.
Rodriguez, E. M., Diaz, C., & Fowler, M. G. (1997). The clinical management of children perinatally exposed to HIV. Primary Care, 24, 643–666.
45.
Rogers, M. F., Schochetman, C., & Hoff, R. (1994). Advances in diagnosis of HIV infection in infants. In P. A. Pizzo & C. M. Wilfert (Eds.), Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents (pp. 219–238). Baltimore: Williams & Wilkins.
46.
Rutstein, R. M., Feingold, A., Meislich, D., Word, B., & Rudy, B. (1997). Protease inhibitor therapy in children with perinatally acquired HIV infection. AIDS, 11, 107–111.
47.
Schmitt, F. A., Dickson, L. R., & Brouwers, P. (1994). Neuropsychological response to antiretroviral therapy in HIV infection. In I. Grant & A. Martin (Eds.), Neuropsychology of HIV infection (pp. 276–294). New York: Oxford University Press.
48.
Seidel, J. F. (1992, November). Pediatric HIV infection and developmental disabilities. Paper presented at the meeting of the American Association on Mental Retardation, New Orleans, LA.
49.
Seligman, M., & Darling, R. B. (1989). Ordinary families, special children: A systems approach to childhood disability.New York: Guilford Press.
50.
Sicklick, M. J., & Rubenstein, A. (1992). Types of HIV infection and the course of the disease. In A. C. Crocker, H. J. Cohen, & T. A. Kastner (Eds.), HIV infection and developmental disabilities: A resource for service providers (pp. 33–42). Baltimore: Brookes.
51.
Stabler, B., & Simeonsson, R. J. (1987). Assessment of hospitalized and critically ill children. In R. J. Simeonsson (Ed.), Psychological and developmental assessment of special children (pp. 305–336). Boston: Allyn & Bacon.
52.
Stuber, M. L. (1991). Children, adolescents, and AIDS. Psychiatric Medicine, 9, 441–454.
53.
Trad, P. V., Kentros, M., Solomon, G. E., & Greenblatt, E. R. (1994). Assessment and psychotherapeutic intervention for an HIV-infected preschool child. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 1338–1345.
54.
Watkins, J. M., Brouwers, P., & Huntzinger, R. (1992). Neuropsychological assessment. In M. L. Stuber (Ed.), Children and AIDS. Washington, DC: American Psychiatric Press.
55.
Whitehead, L. C., Deiner, P. L., & Toccafondi, S. (1990). Family assessment: Parent and professional evaluation. Topics in Early Childhood Special Education, 10, 63–77.
56.
Wolters, P. L., Brouwers, P., Civitello, L., & Moss, H. A. (1997). Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: A longitudinal 24-month follow-up study. AIDS, 11, 1135–1144.
57.
Wolters, P. L., Brouwers, P., & Moss, H. A. (1995). Pediatric HIV disease: Effect on cognition, learning, and behavior. School Psychology Quarterly, 10, 305–328.
58.
Zuckerman, B. (1993). Developmental considerations for drug- and AIDS-affected infants. In R. P. Barth, J. Pietrzak, & M. Ramler (Eds.), Families living with drugs and HIV: Intervention and treatment strategies. New York: Guilford Press.
